Journal of Affective DisordersGenetic & Genomic MedicinePeer-reviewed journal article
Analysis of 50,000 exome-sequenced UK Biobank subjects fails to identify genes influencing probability of psychiatric referral
Abstract
BackgroundDepression is moderately heritable but there is no common genetic variant which has a major effect on susceptibility. It is possible that some very rare variants could have substantial effect sizes and these could be identified from exome sequence data. MethodsData from 50,000 exome-sequenced UK Biobank participants was analysed. Subjects were treated as cases if they had reported having seen a psychiatrist for "nerves, anxiety, tension or depression". Gene-wise weighted burden analysis was performed to see if there were any genes or sets of genes for which there was an excess of rare, functional variants in cases. ResultsThere were 5,872 cases and 43,862 controls. There were 22,028 informative genes but none produced a statistically significant result after correction for multiple testing. Of the 25 genes individually significant at p<0.001 none appeared to be a biologically plausible candidate. No set of genes achieved statistical significance after correction for multiple testing and those with the lowest p values again did not appear to be biologically plausible candidates. LimitationsThe phenotype is based on self-report and the cases are likely to somewhat heterogeneous. The number of cases is on the low side for a study of exome sequence data. ConclusionsThe results conform exactly with the expectation under the null hypothesis. It seems unlikely that depression genetics research will produce findings that might have a substantial clinical impact until far larger samples become available.
- organism: human
- assay: whole-exome sequencing
- research focus: GWAS / association mapping
- approach: statistical model
- Citations
- 8
- FWCI
- 0.59
- Field percentile
- top 34%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Whole exome sequencing in the UK Biobank reveals risk gene SLC2A1 and biological insights for major depressive disorder
Ruoyu Tian, Tian Ge, … Chia‐Yen Chen·medRxiv·May 4, 2021
- Genome-wide gene-environment analyses of major depressive disorder and reported lifetime traumatic experiences in UK Biobank
Jonathan R.I. Coleman, Kirstin Lee Purves, … Gerome D. Breen·bioRxiv·May 13, 2019
- Genome-wide association study of depression phenotypes in UK Biobank (n = 322,580) identifies the enrichment of variants in excitatory synaptic pathways
David M. Howard, Mark J. Adams, … Andrew Mark McIntosh·Nature CommunicationsPeer-reviewed·Apr 11, 2018
- Multiple measures of depression to enhance validity of Major Depressive Disorder in the UK Biobank
Kylie P. Glanville, Jonathan R. I. Coleman, … Cathryn M. Lewis·BJPsych OpenPeer-reviewed·Feb 5, 2021
- Surveying the contribution of rare variants to the genetic architecture of human disease through exome sequencing of 177,882 UK Biobank participants
Quanli Wang, Ryan S. Dhindsa, … AstraZeneca Genomics Initiative·bioRxiv·Dec 13, 2020
- Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions.
David M. Howard, Mark J. Adams, … Andrew Mark McIntosh·Nature NeurosciencePeer-reviewed·Feb 4, 2019